Led by Zhipu AI, Chinese tech companies rise in Hong Kong debut

Led by Zhipu AI, Chinese tech companies rise in Hong Kong debut

Chinese and Hong Kong flags flutter next to bull statues outside the Hong Kong Exchanges at the financial Central district in Hong Kong, China September 14, 2020. REUTERS/Tyrone Siu

Three Chinese technology firms debuted higher on Thursday after raising a combined HK$9.3 billion ($1.19 billion), setting the tone for what investors hope will be a busier year for new listings in Hong Kong.

All of the debutants traded above their offer prices. Artificial intelligence company Zhipu AI, also known as Knowledge Atlas Technology, opened 3.3% higher than its offer price of HK$116.20 apiece and traded around HK$116.40.

Shanghai Iluvatar CoreX, a semiconductor firm, started 31.6% higher than the offer price of HK$144.60, and changed hands at around HK$169.40.

Surgical robotics company Shenzhen Edge Medical jumped 36.4% above the HK$43.24 offer price, and traded at around HK$ 55.50.

The debuts come as Chinese authorities fast-track AI and chip listings to strengthen domestic alternatives to advanced U.S. technology, a backdrop that has drawn issuers across the tech sectors.

Huawei’s AI server spin-off xFusion has hired Citic Securities in preparation for a mainland IPO, while memory chipmaker ChangXin Memory Technologies and Baidu’s AI chip arm Kunlunxin are planning listings too, Reuters has reported.

Zhipu AI, spun out of Tsinghua University, raised HK$4.35 billion at HK$116.20, giving it a valuation near HK$51 billion.

It plans to use the bulk of proceeds for research and development. Cornerstone investors included JSC International Investment Fund and JinYi Capital Multi-Strategy Fund, among others.

Shanghai Iluvatar CoreX, a designer of general-purpose GPUs, raised HK$3.48 billion. Its offer price gave it a market capitalisation near HK$36.8 billion. It earmarked the bulk of its proceeds for R&D across chips, accelerators and software.

Shenzhen Edge Medical raised about HK$1.12 billion, which will fund its R&D, commercialisation, manufacturing capacity and strategic acquisitions, among others.

Its cornerstone investors include Abu Dhabi Investment Authority, OrbiMed, UBS AM Singapore and Tencent’s Huang River.

The trio’s performance on Thursday will also help gauge whether Hong Kong can extend last year’s IPO resurgence, with $37.2 billion raised from 115 new listings, the strongest since 2021, according to LSEG data as of January 5.

The debut pipeline is growing, with MiniMax Group, another Chinese AI firm, and chipmaker OmniVision Integrated Circuits, due to start trading on Friday.

Reuters

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter


This is your last free story for the month. Register to continue reading our content